Introduction
The tumor-suppressor gene PTEN shows somatic mutations in a wide variety of sporadic neoplasias whereas its heterozygous germline mutations are responsible for a cancer-prone syndrome, Cowden disease (MIM 158350), and a related entity known as Bannayan-Riley-Ruvalcaba syndrome (MIM 153480). These diseases are characterized by a progressive development of numerous hypertrophic, hamartomatous and neoplastic lesions involving the skin, mucous membranes, gastrointestinal tract, thyroid, breast, brain and genitor-urinary system. Lipomas, angiomas and macrocephaly are frequently associated. The Proteus syndrome (MIM 176920), characterized by asymmetric and disproportionate overgrowth, cerebriform connective tissue nevi, the presence of an epidermal nevus and dysregulated adipose tissue, was attributed to PTEN germline mutations by one team who referred to this entity as Proteus or Proteus-like syndromes. 1 However, that finding was not confirmed by others 2 who questioned the accuracy of the patients' phenotypic evaluations and suggested misdiagnoses of Proteus syndrome. 3 We describe two patients belonging to distinct Cowden disease families each associated with a germline PTEN mutation whose phenotypes mimicked Proteus syndrome. A secondary molecular event in one patient, a mosaic PTEN wild-type allelic loss, might explain the atypical phenotype.
Materials and methods

Report of cases
In the first family, the proband ( Figure 1a : II 9 ), a 30-yearold woman, had normal skin at birth but 5 days later a lymphatic vascular malformation appeared on her legs, back and abdomen. One month later, a difference in the length of her legs became evident. At 3 years of age, physical examination revealed macrocephaly, a few subcutaneous soft masses on the chest, overgrowth of the left thigh with a large vascular malformation on its anterior face and several lymphatic vascular malformations. At 7 years, four voluminous lipomas infiltrating the chest wall and one in the xyphoid region were surgically removed. At 8 years, two large lipomas in the left femoral triangle and the left thigh under a lymphatic vascular malformation were debulked. At 14 years, a microvesicular thyroid adenoma was removed. At 23 years, a mucinous cystadenoma of the left ovary was excised. At 26 years, the patient suffered a spontaneous fracture of the left hip. She underwent hip replacement and a bulky fibrous angiolipoma under the gluteus maximus was removed during the operation. Two years later, skin examination revealed two small gingival papules and large patchy lymphatic vascular malformations on the upper right and lower left parts of the back, the latter spreading to the left flank, hip and groin. An epidermal nevus following Blaschko's lines on the middle and upper left portion of the back extended to the left shoulder ( Figure 2a ). Marked hypertrophy of both calves was associated with right talipes varus limiting the patient's mobility. Subcutaneous varicosities and capillaries were present on the right thigh (Figure 2b ), leg and sole (Figure 2c ), whereas the big toe and medial ball of the left foot were ballooned and covered with several fibrotic papules (Figure 2d) . Radiographs of the legs showed enlarged and dystrophic bones, diffuse demineralization and soft tissue calcifications in the right thigh. At 30 years, 4 In the second family, the proband (Figure 1b: III 3 ) , a 45-year-old woman, had a lumbar angioma at birth. One month later, overgrowth of the back of her right hand began and subsequently progressed. At 6 years, asymmetric overgrowth of the left leg was visible. One year later, a tumor was surgically removed from her right breast. At 10 years, the extramedullary part of an extensive fibrotic lipoma in the right paravertebral groove, infiltrating T9-T12 and the thoracic spinal canal, was partially removed. Six months later, she developed flaccid paraplegia, followed by an intrathoracic angioma and angiomas of the C7 and T5 vertebrae.
At 35 years, a multiheteronodular goiter was excised. Physical examination revealed macrocephaly, overgrowth of the right hand covered by multiple papules (Figure 3a ) with a voluminous palmar sclerosing fibroma (Figure 3b ), a lipoma of the left groin, a subcutaneous palpable vascular malformation on the left side of the chest and mild left leg overgrowth. At 44 years, intrathoracic arteriovenous shunts responsible for high-output heart failure were embolized and excised.
The other affected family 2 members ( Hypertrophy of the right hand with macrodactyly is associated with multiple fibrotic papules (a) and a voluminous palmar storiform collagenoma (b).
Mosaic PTEN nullizygosity F Caux et al
Methods
Using standard techniques, genomic DNA was extracted from the blood leukocytes of 11 members of family 1 and three members of family 2 who gave their informed consent. DNA was also extracted from various tissue biopsies and cultured skin-lesion fibroblasts from the two families' probands (patients 1 and 2). Some lesioned skin biopsies were subjected to dispase -digestion cleavage to allow separate testing of the epidermal sheet and dermis. PTEN mutations were sought in germline and somatic DNA after PCR-based denaturating gradient gel electrophoresis (DGGE) and dye-terminator sequencing using ABI prism 377 DNA sequencer as described previously. 5 Microsatellite typing to search for 10qLOH was performed as described previously using a colorimetric-based detection (NBT -X phosphate) method for revelation. 6 Six CA repeats flanking the PTEN locus were tested. Only informative markers were used for LOH analysis, that is D10S1765, D10S541, and D10S1739. PCR was performed using 50 ng of DNA template purified from blood leukocytes, cutaneous fibroblastic cells in culture and several frozen lesional biopsies. All allelic typing were repeated at least twice.
Results
PTEN mutation search
A PTEN missense germline variant in exon 5 (c.403A4G; p.I135 V) was found in the seven affected members of family 1 including patient 1 ( Figure 1a ) and was absent in four unaffected individuals. Sequencing of DNA from several biopsied lesions of patient 1 confirmed this PTEN I135 V germline variant. However, for three different lesions, that is the cutaneous fibroma of the left big toe, the epidermal nevus of the shoulder and the lipoma of the right calf, sequencing showed a clear decrease in the wild type allele (Figure 4 ). Sequencing of DNA from several other tissues including cutaneous fibroblastic cells in culture did not reveal any similar pattern and showed the germline variant in a heterozygous state, as observed previously at the leukocyte level. No other PTEN mutation was detected by DGGE. Two affected members of family 2 including patient 2 ( Figure 1b ) had a PTEN germline frameshift mutation in exon 5 (c.491delA; p.K164RfsX2) that was absent in one unaffected individual. DNA from cutaneous biopsy and cultured skin-lesion fibroblasts in patient 2 also contained this mutation, but in the heterozygous state. No other mutation was found in these samples. 
Search for allelic loss
Owing to the tendency to homozygosity observed in the three lesions in patient 1, a loss of heterozygosity (LOH) for three PTEN-flanking markers was sought in DNA extracted from various tissues from the first patient. A clear decrease in intensity was observed for one allele of each marker with the DNA originating from the cutaneous fibroma of the left big toe, the epidermal nevus and the fibrotic lipoma of the right calf, compared to that of the blood leukocytes (Figure 5b ). In contrast, LOH was not found in DNA from normal skin, cultured skin-lesion fibroblasts, other skin lesions or ovarian cyst. Haplotype analysis showed that LOH involved the maternal allele, that is the wild-type allele (Figure 5a ). Separate searches for LOH in the epidermal sheet and the dermis of the cutaneous biopsies of the three lesions showing LOH revealed conservation of heterozygosity in the epidermis but LOH in the dermis sample (Figure 5c ). No evidence of LOH was found for DNA extracted from cutaneous fibroblast cells in culture and from a right hand lesion biopsy from patient 2.
Discussion
We describe two families that had 12 members with manifestations of Cowden disease. The diagnosis was confirmed by genetic analysis demonstrating a PTEN mutation in the nine affected patients for whom blood samples were available. For family 1, the p.I135 V PTEN variant had previously been identified in another family with Bannayan-Riley-Ruvalcaba syndrome. 7 To our knowledge, the functional consequence of this variant is not known, but it is probably deleterious because missense mutations of amino acids 133 and 136 were previously found to be responsible for the loss of PTEN lipidphosphatase activity. 8 The cosegregation of the disease with the variant in the family 1 ( Figure 1 ) is demonstrative of linkage and single nucleotide polymorphism has never been described in this codon despite extensive human PTEN exploration in recent years. The mutation observed in family 2 (c.491delA) was also reported in another Cowden disease family. 9 It causes the synthesis of a non-functional truncated protein so both these mutations are very probably responsible of the disease. Our patients 1 and 2 had an atypical Cowden disease phenotype that could evoke Proteus syndrome. Both women had complex congenital dysmorphisms, including overgrowth of the legs, lipomatosis, vascular malformations and, in patient 1, a linear epidermal nevus and ovarian cystadenoma. However, they strictly do not meet the revised diagnostic criteria for Proteus syndrome. 10 -12 The foot and hand hypertrophic malformations presented by both patients (Figure 2c, d and 3) are different from the cerebriform connective tissue nevi of the palm or sole observed in Proteus syndrome. 12 On the other hand, several findings including macrocephaly, thyroid adenoma, fibrocystic breast, gingival papules for the patient 1, and macrocephaly, multinodular goiter, multiple breast tumors for the patient 2, are suggestive of the ordinary nonsegmental Cowden disease.
To explain these additional manifestations in our patients, we looked for a second molecular event at the PTEN locus in lesional tissues. Three lesions in patient 1 show a tendency to homozygosity for PTEN mutation. This finding was confirmed by a decrease in intensity of the wild type Mosaic PTEN nullizygosityallele of PTEN flanking markers suggestive of deletion of all or part of the 10q chromosomal arm in a subset of cells of these lesions. Interestingly, the deleted allele in each lesion carries the wild type PTEN allele. Availability of samples did not allow us to perform FISH experiments to investigate the PTEN locus at the cellular level.
These data are reminiscent of two recently published observations. The first one described a patient with a 'Proteus-like' syndrome associating congenital hemihypertrophy of the right leg, macrocephaly, epidermal nevi arranged in whirls, multiple lipomas and massive arteriovenous malformations involving the muscles and bones of the right leg reported by Zhou et al. 13 That patient harbored a germline PTEN mutation (R335X) and a secondhit PTEN mutation (R130X) on the opposite allele in lesioned tissues, for example an epidermal nevus, a lipoma and an arteriovenous malformation. The second described a 3-year-old boy reported as Proteus syndrome by Loffeld et al 14 showing an extensive epidermal nevus, macrocephaly, vascular malformation affecting both lower limbs, asymmetric hypertrophy of a leg, localized macrodactyly, and abdominal lipoma. This patient has a missense mutation of PTEN (p.Y68D) inherited from his mother who shows features of Cowden syndrome, as do several members of her family. Sequence analysis of the PTEN exon 3 from DNA extracted from curettings of the epidermal nevus shows a profile of homozygosity for the pY68D mutation evoking a PTEN wild-type allele loss. The molecular data of these patients including ours showed that a heterozygous germline PTEN mutation, which is usually causative of Cowden disease, associated with a mosaic inactivation of the wild-type PTEN allele, may be associated with multiple dysmorphisms suggestive of other diseases (Proteus syndrome, Klippel-Trenaunay syndrome). These different lesions could be explained by the bi-allelic PTEN inactivation and a complete loss of the PTEN function responsible for hypertrophy of the affected tissues. The lesions in patient 2 are also probably related to a complete PTEN inactivation in specific tissues, even though we were unable to demonstrate a second PTEN alteration probably because of the small number of available samples. We indeed only tested one biopsy of the pathological skin and as we experimented for the first patient several skin samples from different areas have to be tested to demonstrate mosaicism. On the other hand, other mechanisms of inactivation like epigenetic silencing or a transcriptional defect cannot be excluded.
The same phenomenon is well known as 'Knudson's hypothesis' in malignant tumors arising in cancer-prone syndromes for which extensive demonstrations of a second hit restricted to tumoral cells was obtained. 15 A similar mechanism with a second hit occurring earlier during development was postulated for autosomal-dominant genodermatoses 16 
